prasad1
Active member
As international vaccine companies and academic institutions race the clock to deliver a safe Covid-19 vaccine, all eyes are on India that makes 60% of the world’s vaccines. And within India, if there is one destination that all of them are making a beeline for it is Hyderabad. The city has the capacity to churn out well over a third of the global vaccine supply. Be it India’s first indigenous Covid-19 vaccine candidate Covaxin or Russia’s Sputnik V, Johnson & Johnson’s Ad26.Cov2.S, FluGen’s CoroFlu or even Sanofi’s under development vaccine candidates, all have a Hyderabad connect. Whether a successful Covid-19 vaccine is developed in Hyderabad or not, a vaccine developed anywhere in the world will be churned out of Hyderabad, says Dr Varaprasad Reddy, founder & chairman, Shantha Biotechnics Ltd.
timesofindia.indiatimes.com
Hyderabad: Why is 'City of Nizams' also known as world’s vaccine capital | City - Times of India Videos
As international vaccine companies and academic institutions race the clock to deliver a safe Covid-19 vaccine, all eyes are on India that makes 60% of the world’s vaccines. And within India, if there is one destination that all of them are making a beeline for it is Hyderabad. The city has the...
timesofindia.indiatimes.com
